Mandate

Vinge advises Carl Lamm in connection with recapitalization offer and listing

May 13, 2008

Vinge advises Carl Lamm Holding AB (publ) in connection with the recapitalization offer regarding Carl Lamm AB (publ) and the listing of Carl Lamm Holding. On 6 May 2008, Carl Lamm Holding announced a public offer to acquire all shares in Carl Lamm. The consideration in the offer is a combination of cash and shares in Carl Lamm Holding. The total value of the offer amounts to approximately SEK 592 million. Carl Lamm Holding is expected to be listed on OMX Nordic Exchange Stockholm on or about 26 June 2008.


Jan Lombach, Mattias Friberg and Emil Hedberg are coordinating the work and are proving corporate and capital markets advice. Mattias Schömer, Maria Schultzberg, Maria Doeser and Johan Bocander are providing tax advice. Mikael Ståhl, Paula Röttorp and Christina O Rosén are providing advice regarding the financing.


The IT company Carl Lamm operates in the document and information management industry and has a nationwide organization with operations in 25 strategic locations in Sweden, offering solutions for customers’ various IT environments. Carl Lamm is the exclusive Swedish distributor for Ricoh products, Philips voice management products, Francotyp-Postalia postage meter systems and distributor for Samsung multifunctional products. Furthermore, the company is a HP Preferred Partner and a Microsoft Gold Partner. Carl Lamm is listed on OMX Nordic Exchange Stockholm.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025